He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

Building local capacity to manufacture drugs, vaccines, and health products is not enough. Officials must work to ensure ...

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

The WHO said Friday it had for the first time prequalified a mpox vaccine -- a move expected to speed up access to the jabs ...

The so-called clinical hold is due to a single report of nerve damage in a patient who received the combination shot in a ...

However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

Patients in the vaccine arm of the trial were shown to have worse outcomes than those in the control arm. [28] Lipopolysaccharide & Derivatives Another important group of compounds derived from ...